157 related articles for article (PubMed ID: 19228774)
1. Notch signaling contributes to the pathogenesis of human osteosarcomas.
Engin F; Bertin T; Ma O; Jiang MM; Wang L; Sutton RE; Donehower LA; Lee B
Hum Mol Genet; 2009 Apr; 18(8):1464-70. PubMed ID: 19228774
[TBL] [Abstract][Full Text] [Related]
2. Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling.
Kolb EA; Gorlick R; Keir ST; Maris JM; Lock R; Carol H; Kurmasheva RT; Reynolds CP; Kang MH; Wu J; Houghton PJ; Smith MA
Pediatr Blood Cancer; 2012 May; 58(5):815-8. PubMed ID: 22052798
[TBL] [Abstract][Full Text] [Related]
3. Bursting the Notch Bubble: New Insights into In Vivo Transcriptional Dynamics.
Vissers C; Kageyama R
Dev Cell; 2019 Aug; 50(4):393-394. PubMed ID: 31430449
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation.
Tanaka M; Setoguchi T; Hirotsu M; Gao H; Sasaki H; Matsunoshita Y; Komiya S
Br J Cancer; 2009 Jun; 100(12):1957-65. PubMed ID: 19455146
[TBL] [Abstract][Full Text] [Related]
5. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of Notch in osteosarcoma.
McManus MM; Weiss KR; Hughes DP
Adv Exp Med Biol; 2014; 804():67-92. PubMed ID: 24924169
[TBL] [Abstract][Full Text] [Related]
7. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
[TBL] [Abstract][Full Text] [Related]
8. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
9. Translational biology of osteosarcoma.
Kansara M; Teng MW; Smyth MJ; Thomas DM
Nat Rev Cancer; 2014 Nov; 14(11):722-35. PubMed ID: 25319867
[TBL] [Abstract][Full Text] [Related]
10. The canonical Notch signaling pathway: unfolding the activation mechanism.
Kopan R; Ilagan MX
Cell; 2009 Apr; 137(2):216-33. PubMed ID: 19379690
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of long non-coding RNAs in osteosarcoma.
Liao X; Wei R; Zhou J; Wu K; Li J
Front Mol Biosci; 2024; 11():1327459. PubMed ID: 38516191
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the proximity-dependent nuclear interactome for the oncoprotein NOTCH1 in live cells.
Torres HM; Fang F; May DG; Bosshardt P; Hinojosa L; Roux KJ; Tao J
J Biol Chem; 2024 Jan; 300(1):105522. PubMed ID: 38043798
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis.
Nirala BK; Yamamichi T; Yustein JT
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511127
[TBL] [Abstract][Full Text] [Related]
14. Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.
Todosenko N; Khlusov I; Yurova K; Khaziakhmatova O; Litvinova L
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240338
[TBL] [Abstract][Full Text] [Related]
15. The Intricate Notch Signaling Dynamics in Therapeutic Realms of Cancer.
Sen P; Ghosh SS
ACS Pharmacol Transl Sci; 2023 May; 6(5):651-670. PubMed ID: 37200816
[TBL] [Abstract][Full Text] [Related]
16. Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells.
Chang YT; Chiu I; Wang Q; Bustamante J; Jiang W; Rycaj K; Yi S; Li J; Kowalski-Muegge J; Matsui W
Blood Adv; 2023 Jul; 7(14):3551-3560. PubMed ID: 37042949
[TBL] [Abstract][Full Text] [Related]
17. NOTCH Signaling in Osteosarcoma.
Zhang Z; Wu W; Shao Z
Curr Issues Mol Biol; 2023 Mar; 45(3):2266-2283. PubMed ID: 36975516
[TBL] [Abstract][Full Text] [Related]
18. Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.
Taylor AM; Sun JM; Yu A; Voicu H; Shen J; Barkauskas DA; Triche TJ; Gastier-Foster JM; Man TK; Lau CC
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887382
[TBL] [Abstract][Full Text] [Related]
19.
Bae Y; Zeng HC; Chen YT; Ketkar S; Munivez E; Yu Z; Gannon FH; Lee BH
JBMR Plus; 2022 May; 6(5):e10623. PubMed ID: 35509638
[TBL] [Abstract][Full Text] [Related]
20. Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma.
Torres HM; VanCleave AM; Vollmer M; Callahan DL; Smithback A; Conn JM; Rodezno-Antunes T; Gao Z; Cao Y; Afeworki Y; Tao J
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
